Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective study of prognosis prediction and precise treatment strategies for macrolide-unresponsive Mycoplasma pneumoniae pneumonia in children
ChiCTR2500103218Phase 4Not yet recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- May 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of doxycycline, azithromycin and methylprednisolone in Mycoplasmal pneumonia and Macrolide-resistant Mycoplasma pneumoniae pneumonia (MRMP) (5 arms), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoints: Adverse drug reaction and Proportion of refractory Mycoplasma pneumoniae pneumonia. Planned start May 2025; status: not yet recruiting.
02
Drugs
doxycyclineazithromycinmethylprednisolone
03
Conditions
Mycoplasmal pneumoniaMacrolide-resistant Mycoplasma pneumoniae pneumonia (MRMP)
Beyond the preview
Go deeper on ChiCTR2500103218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103218.